Most Recent Articles about SNY
Regeneron, Alnylam Extend Collaboration for RNAi Therapeutics Apr 09, 2019 - Regeneron (REGN) extends collaboration agreement with Alnylam to develop new RNAi therapeutics for diseases of the eye and central nervous system (CNS).
AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes Mar 28, 2019 - AstraZeneca's (AZN) Forxiga gets approval in Japan for type I diabetes.
Lilly (LLY) Signs New Immunology Deal With Private Biotech Mar 27, 2019 - Eli Lilly (LLY) gets an exclusive, worldwide license to develop and commercialize a novel immunometabolism target from private biotech, ImmuNext.

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
ABT Abbott Laboratories NYSE $67.67 $118.71B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals